TC
ENZY

TFS Capital’s Enzymotec Ltd ENZY Stock Holding History

TFS Capital’s Portfolio ENZY Stock Details ENZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-13,375
Closed -$94K – 995
2016
Q3 		$94K Sell
13,375
-4,926
-27% -$39.5K 0.02% 655
2016
Q2 		$153K Buy
+18,301
New +$152K 0.03% 794
2014
Q4 		– Sell
-33,089
Closed -$221K – 1276
2014
Q3 		$221K Sell
33,089
-1,655
-5% -$17.9K 0.02% 842
2014
Q2 		$471K Buy
34,744
+11,637
+50% +$195K 0.04% 670
2014
Q1 		$509K Buy
23,107
+13,371
+137% +$354K 0.03% 728
2013
Q4 		$263K Buy
+9,736
New +$232K 0.01% 1155

Other funds holding ENZY

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

TFS Capital's ENZY Position: Q4 2016 in Review

TFS Capital sold out of Enzymotec Ltd (ENZY) in Q4 2016, closing a stake of 13,375 shares — an estimated $94K sold.

TFS Capital first reported a position in ENZY in Q4 2013 and held it in 6 quarters. The position peaked at $509K in Q1 2014. 32 funds tracked by Wall St. Rank hold ENZY as of Q4 2016.

  • TFS Capital reported no remaining Enzymotec Ltd position as of Q4 2016 after selling out during the quarter.
  • TFS Capital sold 13,375 Enzymotec Ltd shares in Q4 2016, an estimated $94K.
  • TFS Capital first reported a position in Enzymotec Ltd in Q4 2013 and held it in 6 quarters.
  • TFS Capital's Enzymotec Ltd position peaked at $509K in Q1 2014.
  • 32 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q4 2016.

Based on TFS Capital's 13F filing for Q4 2016, filed 20 Jan 2017.